Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Clinical
Phase II
Phase II
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II
AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial
Firstwordpharma News
-
February 21, 2019
Phase II
Syros Announces New Data from Phase 2 Trial of SY-1425 in Combination with Azacitidine Demonstrating High Response Rates, Rapid Onset of Action and Favorable...
Phase II
Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase as Pre-treatment Ahead of Gene Therapy in Select Indications
Phase II
Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances
Phase II
Karuna Therapeutics Announces KarXT Met Primary Endpoint in Phase 2 Clinical Trial of Acute Psychosis in Patients with Schizophrenia
Phase II
InflaRx Receives Approval to Initiate Phase IIa Clinical Trial with ...
Biospace News
-
February 27, 2019
0
Phase II
Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase...
Biospace News
-
April 24, 2019
0
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for...
Firstwordpharma News
-
July 18, 2019
0
Phase II
Sensorion Announces the Positive Data Safety Monitoring Board (DSMB) Review and...
Firstwordpharma News
-
May 15, 2019
0
Phase II
Positive Phase II Data Further Highlights Clinical Proof of Concept for...
Biospace News
-
May 10, 2019
0
1
2
3
...
34
Page 1 of 34
- Advertisement -
MOST POPULAR
EnduRx Pharmaceuticals Awarded $1.4MM of a $1.75MM Grant to Collaborate with...
March 1, 2020
Senzer’s ISO Certification: A First for the Pharmaceutical Cannabinoid Sector
February 19, 2019
EIP Pharma to Host KOL Breakfast Briefing on Potential of Neflamapimod...
June 7, 2019
CTI BioPharma to Present at the JMP Securities Life Sciences Conference...
June 13, 2019
Load more
HOT NEWS
Deals
PrimeVax Immuno-Oncology Signs Exclusive Worldwide Dengue Virus License with US Army...
Others
Merck KGaA offloads Allergopharma allergy business to Dermapharm
Deals
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
Newer Targets
Maze Therapeutics Opens Its Doors to Study Modifier Gene-Related Diseases
